Literature DB >> 27198053

IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance.

T Imamura1,2, M Yano1, D Asai1, A Moriya-Saito3, S-I Suenobu2,4, D Hasegawa2,5, T Deguchi2,6, Y Hashii2,7, H Kawasaki2,8, H Hori2,6, K Yumura-Yagi2,9, J Hara2,10, K Horibe2,3, A Sato2,11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27198053     DOI： 10.1038/leu.2016.128

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.

Authors:  R Marke; J Havinga; J Cloos; M Demkes; G Poelmans; L Yuniati; D van Ingen Schenau; E Sonneveld; E Waanders; R Pieters; R P Kuiper; P M Hoogerbrugge; G J L Kaspers; F N van Leeuwen; B Scheijen
Journal:  Leukemia       Date:  2015-12-29       Impact factor: 11.528

2.  ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.

Authors:  Lilian Kuster; Reinhard Grausenburger; Gerhard Fuka; Ulrike Kaindl; Gerd Krapf; Andrea Inthal; Georg Mann; Maximilian Kauer; Johannes Rainer; Reinhard Kofler; Andrew Hall; Markus Metzler; Lüder Hinrich Meyer; Claus Meyer; Jochen Harbott; Rolf Marschalek; Sabine Strehl; Oskar A Haas; Renate Panzer-Grümayer
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

3.  Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Authors:  Courtney L Jones; Teena Bhatla; Roy Blum; Jinhua Wang; Steven W Paugh; Xin Wen; Wallace Bourgeois; Danielle S Bitterman; Elizabeth A Raetz; Debra J Morrison; David T Teachey; William E Evans; Michael J Garabedian; William L Carroll
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia.

Authors:  E Waanders; V H J van der Velden; C E van der Schoot; F N van Leeuwen; S V van Reijmersdal; V de Haas; A J Veerman; A Geurts van Kessel; P M Hoogerbrugge; R P Kuiper; J J M van Dongen
Journal:  Leukemia       Date:  2010-11-19       Impact factor: 11.528

5.  CREBBP mutations in relapsed acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Jinghui Zhang; Lawryn H Kasper; Stephanie Lerach; Debbie Payne-Turner; Letha A Phillips; Sue L Heatley; Linda Holmfeldt; J Racquel Collins-Underwood; Jing Ma; Kenneth H Buetow; Ching-Hon Pui; Sharyn D Baker; Paul K Brindle; James R Downing
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

6.  Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hideki Yoshida; Toshihiko Imamura; Akiko M Saito; Yoshihiro Takahashi; So-ichi Suenobu; Daiichiro Hasegawa; Takao Deguchi; Yoshiko Hashii; Hirohide Kawasaki; Mikiya Endo; Hiroki Hori; Nobuhiro Suzuki; Yoshiyuki Kosaka; Koji Kato; Keiko Yumura-Yagi; Junichi Hara; Megumi Oda; Atsushi Sato; Keizo Horibe
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.

Authors:  Ila Joshi; Toshimi Yoshida; Nilamani Jena; Xiaoqing Qi; Jiangwen Zhang; Richard A Van Etten; Katia Georgopoulos
Journal:  Nat Immunol       Date:  2014-02-09       Impact factor: 25.606

8.  IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.

Authors:  Daisuke Asai; Toshihiko Imamura; So-ichi Suenobu; Akiko Saito; Daiichiro Hasegawa; Takao Deguchi; Yoshiko Hashii; Kimikazu Matsumoto; Hirohide Kawasaki; Hiroki Hori; Akihiro Iguchi; Yoshiyuki Kosaka; Koji Kato; Keizo Horibe; Keiko Yumura-Yagi; Junichi Hara; Megumi Oda
Journal:  Cancer Med       Date:  2013-05-09       Impact factor: 4.452
  8 in total
  6 in total

Review 1.  The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.

Authors:  René Marke; Frank N van Leeuwen; Blanca Scheijen
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

2.  Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Elisabeth M P Steeghs; Judith M Boer; Alex Q Hoogkamer; Aurélie Boeree; Valerie de Haas; Hester A de Groot-Kruseman; Martin A Horstmann; Gabriele Escherich; Rob Pieters; Monique L den Boer
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

3.  CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.

Authors:  Dafné Moreno Lorenzana; María Del Rocío Juárez Velázquez; Adriana Reyes León; Daniel Martínez Anaya; Adrián Hernández Monterde; Consuelo Salas Labadía; María Del Pilar Navarrete Meneses; Marta Zapata Tarrés; Luis Juárez Villegas; Berenice Jarquín Ramírez; Rocío Cárdenas Cardós; Martha Herrera Almanza; Rogelio Paredes Aguilera; Patricia Pérez Vera
Journal:  J Pathol Clin Res       Date:  2021-04-23

Review 4.  Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.

Authors:  Kamil Kośmider; Katarzyna Karska; Agata Kozakiewicz; Monika Lejman; Joanna Zawitkowska
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

5.  Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways.

Authors:  Miriam Butler; Britt M T Vervoort; Dorette S van Ingen Schenau; Lieneke Jongeneel; Jordy C G van der Zwet; René Marke; Jules P P Meijerink; Blanca Scheijen; Laurens T van der Meer; Frank N van Leeuwen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

6.  Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations

Authors:  Željko Antić; Jiangyan Yu; Simon V Van Reijmersdal; Anke Van Dijk; Linde Dekker; Wouter H Segerink; Edwin Sonneveld; Marta Fiocco; Rob Pieters; Peter M Hoogerbrugge; Frank N Van Leeuwen; Ad Geurts Van Kessel; Esme Waanders; Roland P Kuiper
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.